Sales & Marketing News | pharmaphorum

News

Appeal finds NICE must reconsider Alzheimer's drugs

Lilly and Eisai's bid to secure NHS coverage of their Alzheimer's therapies has entered a new phase, after an appeal of last year's rejection by NICE.

News

Generic semaglutide in India, and other weight-loss news

Novo Nordisk is facing generic semaglutide in India, Atrogi is testing a new weight loss approach, and Structure has more data with its oral GLP-1.

News

Alfasigma claims early FDA nod for ex-GSK liver drug

Alfasigma has claimed the first approval, in the US, for linerixibat, a drug for liver disease PBC licensed from GSK for $690m a few days ago.

News

J&J gets FDA okay for psoriasis drug icotrokinra

Johnson & Johnson's much-anticipated oral IL-23 drug, icotrokinra, has claimed FDA approval as Icotyde for first-line treatment of plaque psoriasis.

News

First MHRA/NICE aligned guidance due in June

The aligned regulatory pathway for UK drugs regulator MHRA and reimbursement authority NICE gets underway on 1st April.

News

US court says pharma giants must face False Claims suit

An appeals court in the US has said AbbVie, AstraZeneca, Novartis, and Sanofi must defend claims they defrauded federal and state governments.

Appeal finds NICE must reconsider Alzheimer's drugs

Generic semaglutide in India, and other weight-loss news

Alfasigma claims early FDA nod for ex-GSK liver drug

J&J gets FDA okay for psoriasis drug icotrokinra

First MHRA/NICE aligned guidance due in June

US court says pharma giants must face False Claims suit

UK Health Secretary resigns, sparking leadership speculation

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks